282 related articles for article (PubMed ID: 26095379)
1. A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.
Kholia S; Jorfi S; Thompson PR; Causey CP; Nicholas AP; Inal JM; Lange S
J Extracell Vesicles; 2015; 4():26192. PubMed ID: 26095379
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.
Lange S; Rocha-Ferreira E; Thei L; Mawjee P; Bennett K; Thompson PR; Subramanian V; Nicholas AP; Peebles D; Hristova M; Raivich G
J Neurochem; 2014 Aug; 130(4):555-62. PubMed ID: 24762056
[TBL] [Abstract][Full Text] [Related]
4. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
7. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
8. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
9. Post-Translational Deimination of Immunological and Metabolic Protein Markers in Plasma and Extracellular Vesicles of Naked Mole-Rat (
Pamenter ME; Uysal-Onganer P; Huynh KW; Kraev I; Lange S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671738
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase and deiminated proteins are detected throughout early halibut ontogeny - Complement components C3 and C4 are post-translationally deiminated in halibut (Hippoglossus hippoglossus L.).
Magnadóttir B; Bragason BT; Bricknell IR; Bowden T; Nicholas AP; Hristova M; Guðmundsdóttir S; Dodds AW; Lange S
Dev Comp Immunol; 2019 Mar; 92():1-19. PubMed ID: 30395876
[TBL] [Abstract][Full Text] [Related]
11. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
13. Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability.
Lange S; Gögel S; Leung KY; Vernay B; Nicholas AP; Causey CP; Thompson PR; Greene ND; Ferretti P
Dev Biol; 2011 Jul; 355(2):205-14. PubMed ID: 21539830
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment.
Kosgodage US; Matewele P; Mastroianni G; Kraev I; Brotherton D; Awamaria B; Nicholas AP; Lange S; Inal JM
Front Cell Infect Microbiol; 2019; 9():227. PubMed ID: 31316918
[TBL] [Abstract][Full Text] [Related]
15. Deimination Protein Profiles in
Criscitiello MF; Kraev I; Petersen LH; Lange S
Front Immunol; 2020; 11():651. PubMed ID: 32411128
[TBL] [Abstract][Full Text] [Related]
16. Protein Deimination and Extracellular Vesicle Profiles in Antarctic Seabirds.
Phillips RA; Kraev I; Lange S
Biology (Basel); 2020 Jan; 9(1):. PubMed ID: 31936359
[TBL] [Abstract][Full Text] [Related]
17. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
U KP; Subramanian V; Nicholas AP; Thompson PR; Ferretti P
Biochim Biophys Acta; 2014 Jun; 1843(6):1162-71. PubMed ID: 24607566
[TBL] [Abstract][Full Text] [Related]
18. The Proteome and Citrullinome of
Magnadóttir B; Kraev I; Dodds AW; Lange S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467210
[TBL] [Abstract][Full Text] [Related]
19. Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.
Rast JP; D'Alessio S; Kraev I; Lange S
Dev Comp Immunol; 2021 Dec; 125():104225. PubMed ID: 34358577
[TBL] [Abstract][Full Text] [Related]
20. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]